Table 1 Characteristics of the sample and according to the place of care

Median Age (Q1; Q3)

89 (84;92)

88 (83;92)

89 (84.5;93)

0.169

Gender. % Female

71.6

76.8

60

<0.001

Male

28.4

23.2

40

Type of nursing home. % Private

68.2

68.5

67.7

0.868

Geriatric Assessment. %

 Barthel <60

63.7

73

43.9

< 0.001

 FAC <3

54.6

63.1

34.3

< 0.001

 GDS 6-7

43.8

54

22.4

< 0.001

 Malnutrition

64

62.9

66.3

0.574

Median Charlson (Q1; Q3)

2 (1,3)

3 (1;4)

2 (1;3)

0.415

Median symptom evolution time (Q1; Q3)

3 (1;7)

3 (1;7))

3 (1;6.8)

0.141

Symptoms. %

 Cough

30.1

28.4

33.8

0.258

 Respiratory failure (SatO2 ≤ 92%)

70.2

65.1

81.5

< 0.001

 Tachypnea (FR ≥ 30 rpm)

18.9

16.6

23.8

0.08

 Dyspnea

16.2

12.8

23.8

0.005

 Fever (Tª ≥ 38ºC)

44.2

42.6

47.7

0.328

 Delirium

19.6

20.4

17.7

0.516

 Functional impairment

20

15.6

30

< 0.001

 Falls

3.8

1.4

9.2

< 0.001

 Eating Disorder

18.6

18.3

19.2

0.828

Treatment %

 Hydroxychloroquine

64.2

59.2

75.4

0.001

 Lopinavir/Ritonavir

5

0

16.2

< 0.001

 Azithromycin

53.2

48.1

64.6

0.002

 Ceftriaxone

29.4

21.1

47.7

< 0.001

 Amoxicillin-Clavulanic Acid

25.5

23.5

30

0.16

 Other Antibiotics

28.4

20.8

45.4

< 0.001

 Corticosteroids

26.7

18

46.2

< 0.001

 HBPM

24.1

6.6

63.1

< 0.001

60-day mortality %

36.8

34.9

40.8

0.253

Visits to emergency department 60 days %

22

8.3

20.2

< 0.001

Hospital admissions 60 days %

7.2

4.5

13.2

0.002

Place of Death. % (N 154)

 Nursing home

70.1

98

16.9

< 0.001

 Hospitalization ward

24.7

1

69.9

 Emergency department

3.3

1

7.5

 Palliative care unit

1.9

0

5.6